| • Providers and commissioners of wet-AMD clinical services should plan services based on realistic estimates of wet-AMD incidence. |
| • Follow best evidence in anti-VEGF medication care. |
| • Maintain high standard of aseptic technique for intra-vitreal injections. |
| • Consider electronic patient records, electronic prescriptions, and audit tools. |
| • Consider pre-injection checklist and ‘time out', especially for high volume and/or mixed surgical schedules/lists. |
| • Ensure adequate stock of anti-VEGF medication is in place in injection facility. |
| • Alarmed refrigerators for anti-VEGF agent storage and reliable medication supply services are vital. |
